208 related articles for article (PubMed ID: 24525051)
1. Which antibiotic for hospital acquired pneumonia caused by MRSA?
Muscedere J
BMJ; 2014 Feb; 348():g1469. PubMed ID: 24525051
[No Abstract] [Full Text] [Related]
2. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Alaniz C; Pogue JM
Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
[TBL] [Abstract][Full Text] [Related]
3. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Twilla JD; Gelfand MS; Cleveland KO; Usery JB
J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Estes L; Orenstem R
Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
[No Abstract] [Full Text] [Related]
5. Antimicrobial agents in treatment of MRSA infections.
Johnson MD; Decker CF
Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282
[No Abstract] [Full Text] [Related]
6. Treatment of methicillin-resistant Staphylococcus aureus surgical site infections.
Santayana EM; Jourjy J
AACN Adv Crit Care; 2011; 22(1):5-12; quiz 14. PubMed ID: 21297385
[No Abstract] [Full Text] [Related]
7. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
8. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Chavanet P
Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896
[TBL] [Abstract][Full Text] [Related]
9. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
[TBL] [Abstract][Full Text] [Related]
10. Management of methicillin-resistant Staphylococcus aureus pneumonia.
Luna CM; Boyeras Navarro ID
Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
12. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
Peyrani P; Ramirez J
Curr Opin Infect Dis; 2015 Apr; 28(2):164-70. PubMed ID: 25692268
[TBL] [Abstract][Full Text] [Related]
13. [Antibiotics for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)].
Stahlmann R
Pneumologie; 2014 Oct; 68(10):676-84. PubMed ID: 25290922
[TBL] [Abstract][Full Text] [Related]
14. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Schmidt-Ioanas M; de Roux A; Lode H
Curr Opin Crit Care; 2005 Oct; 11(5):481-6. PubMed ID: 16175036
[TBL] [Abstract][Full Text] [Related]
15. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
Powers JH; Ross DB; Lin D; Soreth J
Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
[No Abstract] [Full Text] [Related]
16. Treatment options for nosocomial pneumonia due to MRSA.
Niederman MS
J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
[TBL] [Abstract][Full Text] [Related]
17. What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?
Dumitrescu O; Lina G
Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():1-2. PubMed ID: 24580737
[No Abstract] [Full Text] [Related]
18. Antibiotic treatment against methicillin-resistant Staphylococcus aureus hospital- and ventilator-acquired pneumonia: a step forward but the battle continues.
Torres A
Clin Infect Dis; 2012 Mar; 54(5):630-2. PubMed ID: 22247122
[No Abstract] [Full Text] [Related]
19. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Loffler CA; Macdougall C
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
[TBL] [Abstract][Full Text] [Related]
20. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: controversy continues.
Masuta K; Oba Y; Iwata K
Clin Infect Dis; 2012 Jul; 55(1):161. PubMed ID: 22460960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
